J. M. Lavergne - Concepedia

Author

J. M. Lavergne

Also Known As

J. -M. Lavergne, J. M. LAVERGNE, J. M. Lavergne, J. Maurice Lavergne, J.M. LAVERGNE, J.M. Lavergne, J.‐M. LAVERGNE, J.‐M. Lavergne, J‐M. Lavergne

Publications

575

Citations

H-Index

Concepts

All Affiliations

Inserm Bicêtre Hospital Hôpital américain de paris Radboud University Nijmegen Hemophilia Center of Iran

About

J. M. Lavergne is an author at Inserm specializing in medicine, pathology, and pathogenesis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	493
2	Public Health	3	3	178
3	Epidemiology	2	2	162
4	Immunology	2	2	71
5	Allergy	1	1	16

J. M. Lavergne

Publications

553

Citations

H-Index

Page 1

	Year	Citations
Haemophilia A: database of ncleotide substituttions, deletions, insertions and rearrangements of the factor VIII gene Edward G. D. Tuddenham, D.N. Cooper, Jane Gitschier, Nucleic Acids Research Repetitive MutationsAllelic VariantGenetic DisorderMedicineGenetics	1991	119
Haemophilia B Due to a De Novo Insertion of a Human-Specific Alu Subfamily Member within the Coding Region of the Factor IX Gene Dominique Vidaud, Michel Vidaud, Bruce R. Bahnak, European Journal of Human Genetics Autoimmune DiseaseGeneticsPathogenesisHematologyDe Novo Insertion	1993	115
Ten candidate ADAMTS13 mutations in six French families with congenital thrombotic thrombocytopenic purpura (Upshaw–Schulman syndrome) Agnès Veyradier, J. M. Lavergne, Anne‐Sophie Ribba, Journal of Thrombosis and Haemostasis French FamiliesGenetic DisorderGeneticsGenetic EpidemiologyCandidate Adamts13 Mutations	2004	113
Factor VIII (FVIII) gene mutations in 120 patients with hemophilia A: detection of 26 novel mutations and correlation with FVIII inhibitor development Yohann Repessé, M. Slaoui, D. Ferrandiz, Journal of Thrombosis and Haemostasis Fviii Inhibitor DevelopmentPathogenesisHematologyPathologyGene Mutations	2007	59
Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutations J. C. A. Boekhorst, Ghasem Rastegar Lari, Roseline d’Oiron, Haemophilia GeneticsGenetic EpidemiologyImmunologyPathologyDisease Gene Identification	2008	43
Prophylactic effect of recombinant factor VIIa in factor VII deficient patients Natascha C.J. Mathijssen, Rosalinde Masereeuw, Kitty Verbeek, British Journal of Haematology	2004	38
Defects in type IIA von Willebrand disease: a cysteine 509 to arginine substitution in the mature von Willebrand factor disrupts a disulphide loop involved in the interaction with platelet glycoprotein Ib‐IX J. M. Lavergne, L. DePaillette, Bruce R. Bahnak, British Journal of Haematology Exon 28GeneticsImmunologyPathologyMolecular Genetics	1992	28
Fast and Efficient Mutation Detection Method Using Multiplex PCR and Cycle Sequencing J.‐M. Costa, Pauline Ernault, Dominique Vidaud, Thrombosis and Haemostasis	2000	22
Molecular characterization of Iranian patients with type 3 von Willebrand disease Shirin Shahbazi, Reza Mahdian, F. A., Haemophilia Disease EtiologyGeneticsGenetic EpidemiologyPathologyDisease Gene Identification	2009	16

Page 1